Skip to main content
. Author manuscript; available in PMC: 2024 Jun 29.
Published in final edited form as: Support Care Cancer. 2023 Jun 29;31(7):429. doi: 10.1007/s00520-023-07881-6

Table 2.

Cannabis use prevalence and patterns among; 1) all survey respondents providing sufficient cannabis use data (n=1033), 2) patients endorsing use of cannabis since their cancer diagnosis (n=293), and 3) patients endorsing current cannabis use (n=168).

All respondents (n=1033) Respondents (n) Weighted %
(95% CI)
Ever used cannabis (before dx) 545 49.6 (48.8 – 50.3)
Used cannabis since dx 293 25.9 (25.3 – 26.6)
Considered using cannabis (among those not having used it since dx; n=740) 137 16.6 (16.0 – 17.3)
Currently using cannabis 168 14.7 (14.2 – 15.2)
Used cannabis since dx (n=293) Respondents (n) Weighted %
(95% CI)
Used during cancer treatment (n=283) 170 59.8 (58.4 – 61.2)
Freq of use during treatment (n=170)
1+ time per day 20 12.3 (11.1 – 13.7)
1x per day or almost every day 54 30.1 (28.4 – 31.8)
Few times a week 37 24.2 (22.5 – 26.0)
Few times a month 34 18.6 (17.2 – 20.0)
Once a month or less 8 5.6 (4.7 – 6.7)
A few times 17 9.2 (8.2 – 10.4)
Used cannabis after treatment (n=249) 191 64.2 (62.8 – 65.5)
Freq of use after treatment (n=191)
1+ time per day 16 8.0 (7.1 – 8.9)
1x per day or almost every day 46 23.0 (21.5 – 24.5)
Few times a week 35 20.6 (19.1 – 22.2)
Few times a month 29 14.2 (13.0 – 15.5)
Once a month or less 27 12.5 (11.5 – 13.7)
A few times 36 20.3 (18.9 – 21.8)
Days of use (past 30) – mean (SD) 17.1 (11.2) --
Reasons for use since dx
Medical 126 43.8 (42.3 – 45.2)
Non-medical 54 19.6 (18.5 – 20.8)
Both medical and non-medical 108 36.6 (35.2 – 38.0)
THC:CBD content
Higher THC and lower CBD 74 25.9 (24.7 – 27.2)
Higher CBD and lower THC 36 10.8 (10.0 – 11.7)
Equal THC to CBD 30 11.2 (10.3 – 12.2)
CBD only 48 15.4 (14.4 – 16.4)
Don’t know 100 36.7 (35.3 – 38.1)
Methods of cannabis used*
Smoking 151 52.5 (51.1 – 53.9)
Eating 159 52.9 (51.5 – 54.3)
Drinking 15 5.5 (4.9 – 6.2)
By mouth (pills, tinctures, sublingually) 85 26.6 (25.4 – 27.9)
Vaping (e-cigarette like vaporizer) 55 18.2 (17.1 – 19.3)
Dabbing (waxes or shatter) 17 5.0 (4.4 – 5.5)
Applying (lotion, cream, topical) 76 23.7 (22.5 – 24.9)
Cannabis methods used – mean (SD) 1.9 (1.2) --
Primary method of cannabis use
Smoking 98 37.8 (36.4 – 39.3)
Eating 80 27.0 (25.8 – 28.3)
Drinking 4 1.2 (1.0 – 1.6)
By mouth 49 15.8 (14.9 – 16.9)
Vaping 20 6.7 (6.0 – 7.4)
Dabbing 1 0.3 (0.2 – 0.4)
Applying 36 11.2 (10.3 – 12.1)
Currently using cannabis (n=168) Respondents (n) Weighted %
(95% CI)
Freq of past 30-day use
1+ time per day 24 15.0 (13.7 – 16.5)
1x per day or almost every day 51 28.3 (26.7 – 30.0)
Few times a week 44 27.8 (26.1 – 29.6)
Few times a month 28 17.3 (15.8 – 18.8)
Once a month or less 14 7.0 (6.2 – 7.9)
Only tried it once or twice 6 4.1 (3.4 – 5.0)
Times used per day
1 101 57.3 (55.4 – 59.2)
2 44 29.0 (27.2 – 30.8)
3–4 17 9.9 (8.8 – 11.1)
5–9 3 2.0 (1.5 – 2.7)
20 or more 2 1.8 (1.3 – 2.6)
Reasons for use in the past 30 days
Medical 58 33.5 (31.7 – 35.2)
Non-medical 29 17.8 (16.3 – 19.3)
Both medical and non-medical 80 48.8 (46.9 – 50.7)
Interest in quitting cannabis – mean (SD) 1.8 (1.9) --
Interest in reducing cannabis – mean (SD) 1.9 (2.0) --

Notes: 3 respondents did not answer cannabis items and were excluded from estimates above (n=1033). Current cannabis use was defined as either answering yes to a current cannabis use item (n=148) OR use within the past 30 days (n=165). Quit/reduction interest questions were on a 1–10 scale (1=not at all interested; 10=extremely interested). Abbreviations: CI Confidence Interval; dx=cancer diagnosis; THC= tetrahydrocannabinol; CBD= cannabidiol;

*=

Check all that apply.

Suppositories were re-categorized into “Apply” when endorsed.

Options 10–14 and 15–19 times a day were not endorsed and are not shown here. p-values are from weight-adjusted Chi-square tests.